Secondary prevention of venous thromboembolic complications. Focus on dabigatrane
Venous thromboembolic complications (VTEC) are a frequent pathology accompanied by high lethality. After VTEC the risk of their recurrence not equivalent for all patients remains. The anticoagulant therapy available currently effectively prevents VTEC increasing a possibility of hemorrhages. This me...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Russo |
| Udgivet: |
Remedium Group LTD
2017-12-01
|
| Serier: | Амбулаторная хирургия |
| Fag: | |
| Online adgang: | https://www.a-surgeon.ru/jour/article/view/88 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
